ARENACCIO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 2.523
EU - Europa 1.059
AS - Asia 1.048
SA - Sud America 99
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 3
Totale 4.808
Nazione #
US - Stati Uniti d'America 2.479
SG - Singapore 431
RU - Federazione Russa 375
CN - Cina 352
GB - Regno Unito 178
SE - Svezia 124
DE - Germania 114
VN - Vietnam 86
BR - Brasile 62
FI - Finlandia 62
IT - Italia 58
HK - Hong Kong 40
IE - Irlanda 33
UA - Ucraina 32
JP - Giappone 26
BD - Bangladesh 25
CA - Canada 25
CI - Costa d'Avorio 24
TR - Turchia 23
DK - Danimarca 19
IN - India 18
CO - Colombia 15
AL - Albania 13
AR - Argentina 12
NL - Olanda 12
ID - Indonesia 11
AT - Austria 8
MX - Messico 7
IQ - Iraq 6
PL - Polonia 6
CZ - Repubblica Ceca 5
ES - Italia 5
PH - Filippine 5
ZA - Sudafrica 5
EC - Ecuador 4
FR - Francia 4
KR - Corea 4
AU - Australia 3
DO - Repubblica Dominicana 3
TH - Thailandia 3
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
PK - Pakistan 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
VE - Venezuela 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KY - Cayman, isole 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.777
Città #
Fairfield 286
Ashburn 271
Woodbridge 246
Singapore 209
Dallas 171
Chandler 146
Southend 138
Houston 132
San Jose 118
Wilmington 102
Seattle 101
Cambridge 98
Beijing 66
Ann Arbor 63
Boardman 56
Dearborn 49
Helsinki 41
Hong Kong 39
Nanjing 37
Shanghai 35
Jacksonville 34
Moscow 32
Dublin 31
Council Bluffs 30
Princeton 29
Dong Ket 26
Los Angeles 26
Tokyo 26
Hefei 22
Ho Chi Minh City 21
Redwood City 18
Shenyang 18
Izmir 17
The Dalles 17
Rome 16
Hanoi 15
New York 14
Santa Clara 14
Jinan 13
Munich 13
San Diego 13
Hebei 12
Changsha 11
Denver 10
Frankfurt am Main 10
Kunming 10
Montreal 10
Plano 10
Columbus 9
Jiaxing 9
São Paulo 9
Turku 9
Atlanta 8
London 8
Nanchang 8
Guangzhou 7
Jakarta 7
Chicago 6
Milan 6
Phoenix 6
Tianjin 6
Brno 5
Böblingen 5
Haikou 5
Nuremberg 5
Orem 5
Pune 5
Warsaw 5
Ankara 4
Brooklyn 4
Cali 4
Chennai 4
Falls Church 4
Lanzhou 4
Mumbai 4
Seoul 4
Stockholm 4
Zhengzhou 4
Barranquilla 3
Boston 3
Bremen 3
Buffalo 3
Charlotte 3
Flushing 3
Fort Worth 3
Hangzhou 3
Hải Dương 3
Johannesburg 3
Manchester 3
Miami 3
Rio de Janeiro 3
San Francisco 3
San Paolo di Civitate 3
Taizhou 3
Toronto 3
Tucson 3
Vienna 3
Yubileyny 3
Altamura 2
Amman 2
Totale 3.159
Nome #
Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. 321
MiR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes 271
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant 266
The ADAR1 editing enzyme is encapsidated into HIV-1 virions 260
HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation 257
HIV-1-infected cells transiently express lentiviral RNA shuttled by exosomes 253
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1 231
Uncovering the role of defective HIV-1 in spreading viral infection 230
The Contribution of Extracellular Nef to HIV-Induced Pathogenesis 223
Surface-bound Tat inhibits antigen-specific CD8(+) T-cell activation in an integrin-dependent manner 222
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1 219
HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response 214
HIV‐1 Nef Protein Affects Cytokine and Extracellular Vesicles Production in the GEN2.2 Plasmacytoid Dendritic Cell Line 209
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors 176
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation 176
The intracellular delivery of anti-HPV16 E7 scFvs through engineered extracellular vesicles inhibits the proliferation of HPV-infected cells 175
N-terminal fatty acids of NEFmut are required for the CD8+ t-cell immunogenicity of in vivo engineered extracellular vesicles 162
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells 157
Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications 151
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance 147
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens 138
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion 132
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir 122
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs 96
Totale 4.808
Categoria #
all - tutte 16.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 0 0 48 18 8 17 25 13 29 43
2022/2023405 41 92 16 43 37 70 2 24 36 3 22 19
2023/2024265 13 13 16 23 15 31 41 66 1 4 1 41
2024/2025674 6 7 56 6 6 30 288 135 36 30 43 31
2025/20261.324 116 230 96 139 162 63 185 18 116 135 48 16
2026/2027210 21 19 90 80 0 0 0 0 0 0 0 0
Totale 4.808